OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
30
Results
Show all
Save search
Copy query
Show results for
Unknown
(30)
Publication Date
Release Date
2022
(7)
2021
(4)
2025
(3)
2024
(3)
2023
(3)
2015
(3)
2020
(2)
2009
(2)
2019
(1)
2018
(1)
2014
(1)
Previous
page
1 / 3
You're on page
1
page
2
page
3
Next
page
Sort
by:
Relevance
Page size
10
Early Protocolized Versus Usual Care Rehabilitation for Pediatric Neurocritical Care Patients: A Randomized Controlled Trial.
Not available
S-EPMC7112470
|
biostudies-literature
Cite
Capecitabine and oxaliplatin in the preoperative multimodality treatment of rectal cancer: surgical end points from National Surgical Adjuvant Breast and Bowel Project trial R-04.
Not available
S-EPMC4050205
|
biostudies-literature
Cite
Transformer-based biomarker prediction from colorectal cancer histology: A large-scale multicentric study.
Not available
S-EPMC10507381
|
biostudies-literature
Cite
Remdesivir and Mortality in Patients With Coronavirus Disease 2019.
Not available
S-EPMC9155603
|
biostudies-literature
Cite
Acute respiratory distress syndrome subphenotypes and differential response to simvastatin: secondary analysis of a randomised controlled trial.
Not available
S-EPMC6201750
|
biostudies-literature
Cite
HLA-DRB1*11 and variants of the MHC class II locus are strong risk factors for systemic juvenile idiopathic arthritis.
Not available
S-EPMC4702958
|
biostudies-literature
Cite
Evaluation of a National Quality Improvement Collaborative for Improving Cancer Screening.
Not available
S-EPMC9669819
|
biostudies-literature
Cite
Factors associated with adverse haemodynamic events during the STARRT-AKI trial: a post-hoc secondary analysis.
Not available
S-EPMC12751851
|
biostudies-literature
Cite
A Bayesian reanalysis of the Standard versus Accelerated Initiation of Renal-Replacement Therapy in Acute Kidney Injury (STARRT-AKI) trial.
Not available
S-EPMC9404618
|
biostudies-literature
Cite
Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC8598213
|
biostudies-literature
Cite
Previous
page
1 / 3
You're on page
1
page
2
page
3
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets